Tenaya Therapeutics (TNYA) announced the publications of positive preclinical data for TN-201, the company’s gene therapy candidate for ...
FOXO Technologies (FOXO) has signed a non-binding agreement to acquire Vector Biosource. Vector is an information and biospecimen sourcing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback